Position in CADL
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$78,400
-$12,000 QoQ
Shares Held
16,000
0.0% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in CADL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Boreal Capital Management LLC holds $209,278 across 10 Biotechnology names. CADL ranks #1 (37.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CADL |
Candel Therapeutics, Inc.
This page
|
16,000 | $78,400 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
159 | $70,999 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
29 | $22,406 | |
| 4 | ARGX |
Argenx SE
|
30 | $21,907 | |
| 5 | MRNA |
Moderna, Inc.
|
100 | $5,080 | |
| 6 | XNCR |
Xencor Inc
|
250 | $3,015 | |
| 7 | BNTX |
BioNTech SE
|
30 | $2,666 | |
| 8 | NKTR |
Nektar Therapeutics
|
36 | $2,590 |
All Filings in CADL
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $78,400 | 16,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $90,400 | 16,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $81,600 | 16,000 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $80,960 | 16,000 | Shares | Sole | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||